Non-Alcoholic Fatty Liver Disease (NAFLD) affects a significant portion of the global population, with rates exceeding 40% in ...

Understanding the link between Non-Alcoholic Fatty Liver Disease (NAFLD) and cardiovascular disease is essential. Shared risk factors like obesity and diabetes contribute to both. Pharmaceutical ...

Non-alcoholic fatty liver disease (NAFLD), characterized by excessive hepatic lipid accumulation, poses a high prevalence and can progress to cirrhosis and liver cancer. To enhance preventive and ...

Further analysis showed that Asah1 deficiency increased harmful lipids accumulation, disrupted lipid metabolism, triggered cellular stress, and impaired the cell's waste disposal system.

Nonalcoholic fatty liver disease (NAFLD) is a widespread condition in the Western World. Around 30% of the population have lipid droplets stored in their liver which diminish its function in the ...

Further analysis showed that Asah1 deficiency increased harmful lipids accumulation, disrupted lipid metabolism, triggered cellular stress, and impaired the cell's waste disposal system.

Although all patients with NAFLD need aggressive management of cardiovascular risk factors, it is only patients with NASH who need treatment targeted at the liver disease.